An observational study of Guduchi Extract Tablet
- Registration Number
- CTRI/2020/08/027034
- Lead Sponsor
- Central council for Research in Ayurvedic Sciences Ministry of AYUSH Govt of India New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Healthy individuals (male ♀) subject between the age group of 18-70 years who are living in Jodhpur city.
2.Those who do not have any acute medical condition or chronic medical/surgical condition that requires either immediate or continuous medical monitoring or treatment will be treated as Healthy individuals.
3.Participants who can take medicines orally.
1.Cases of severe vomiting which would affect oral administration of medicine difficult.
2.Positive COVID-19 patient (asymptomatic/symptomatic/mild)
3.Cases of respiratory failure and requiring mechanical ventilation.
4.Combined organ failure requiring ICU monitoring.
5.Patients with uncontrolled Diabetes Mellitus, (HbA1c more than 8.0), Malignant Hypertension (systolic BP more than 180 and diastolic 110), Chronic Renal Failure and those on immunosuppressive medication.
6.Pregnant and Lactating females
7.Any other condition, which as per the investigator would jeopardize the outcome of the trial.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Prevention of incidence of COVID-19 in subjects taking Guduchi Extract Tablet. <br/ ><br>2.Prevention of incidence of non-specific symptoms such as fever, fatigue, cough anorexia, malaise, muscle pain, sore throat, dyspnea, nasal congestion, or headache. <br/ ><br> <br/ ><br>Timepoint: 15 days
- Secondary Outcome Measures
Name Time Method 1.Number of cases Reporting any ADR/AE <br/ ><br>2.Number of patients referred. <br/ ><br>Timepoint: 15 days